Costas et al.
Scheme 1
reactions has stimulated efforts to generate and characterize
analogous intermediates in model systems to serve as syn-
thetic inorganic precedents for the chemistry of these non-
heme diiron enzymes.11,12
The study of synthetic diiron(III)-peroxo intermediates13
has greatly enhanced our understanding of the corresponding
species in proteins. Three diiron(III)-peroxo complexes have
been crystallographically characterized,14-16 and the structure
of a fourth one has been deduced by EXAFS analysis.17
While detailed thermodynamic18 and kinetic19-23 studies on
dioxygen binding to some diiron(II) complexes have been
reported, the factors that affect subsequent decomposition
of these peroxo complexes and their oxidative reactivities
with substrates are much less well understood.24,25 In contrast,
detailed studies have been reported of related copper and
nickel complexes that generate peroxo intermediates that
effect intramolecular ligand oxidation26,27 and, in some cases,
intermolecular oxidation of added substrates.28-32
(O2CC6H5)]2+ reacted with PPh3 and 2,4-di-tert-butylphenol,
unlike its structurally characterized benzimidazole analogue
(N-Et-HPTB, Scheme 1),15 which was unreactive toward
these substrates. Thus a change from pendant benzimidazoles
to pyridines elicits a dramatic change in reactivity. In this
paper, we have extended our initial studies to a series of
Previously, we reported the generation and characterization
of a (µ-1,2-peroxo)diiron(III) complex from the diiron(II)
precursor [Fe2(HPTP)(O2CC6H5)]X233 (see Scheme 1).24 Our
initial studies showed that the O2 adduct of [Fe2(HPTP)-
[FeII (HPTP)] complexes bridged by one or two carboxylates.
2
The crystal structures of two of these precursor complexes
are reported, as well as kinetic studies for the formation and
decay of their O2 adducts. The reactivities of the O2 adducts
depend on the number of carboxylate bridges present. These
differences provide insight into some of the factors that
modulate the stability and oxidative power of the (µ-1,2-
peroxo)diiron(III) unit in chemistry and biology.
(10) Shu, L.; Nesheim, J. C.; Kauffmann, K.; Mu¨nck, E.; Lipscomb, J. D.;
Que, L., Jr. Science 1997, 275, 515-518.
(11) Que, L., Jr. J. Chem. Soc., Dalton Trans. 1997, 3933-3940.
(12) Du Bois, J.; Mizoguchi, T. J.; Lippard, S. J. Coord. Chem. ReV. 2000,
200-202, 443-485.
(13) Girerd, J.-J.; Banse, F.; Simaan, A. J. Struct. Bonding 2000, 97, 143-
177.
(14) Ookubo, T.; Sugimoto, H.; Nagayama, T.; Masuda, H.; Sato, T.;
Tanaka, K.; Maeda, Y.; Okawa, H.; Hayashi, Y.; Uehara, A.; Suzuki,
M. J. Am. Chem. Soc. 1996, 118, 701-702.
Experimental Section
Synthesis. The dinucleating ligand H-HPTP was synthesized
following the published procedure.34 The diiron(II) complexes 1-5
(15) Dong, Y.; Yan, S.; Young, V. G., Jr.; Que, L., Jr. Angew. Chem., Int.
Ed. Engl. 1996, 35, 618-620.
were prepared following the published procedure for [FeII (HPTP)-
(16) Kim, K.; Lippard, S. J. J. Am. Chem. Soc. 1996, 118, 4914-4915.
(17) Dong, Y.; Zang, Y.; Shu, L.; Wilkinson, E. C.; Que, L., Jr.; Kauffmann,
K.; Mu¨nck, E. J. Am. Chem. Soc. 1997, 119, 12683-12684.
(18) Sugimoto, H.; Nagayama, T.; Maruyama, S.; Fujinami, S.; Yasuda,
Y.; Suzuki, M.; Uehara, A. Bull. Chem. Soc. Jpn. 1998, 71, 2267-
2279.
(19) (a) Feig, A. L.; Becker, M.; Schindler, S.; van Eldik, R.; Lippard, S.
J. Inorg. Chem. 1996, 35, 2590-2601. (b) Feig, A. L.; Becker, M.;
Schindler, S.; van Eldik, R.; Lippard, S. J. Inorg. Chem. 2003, 42,
3704
2
24
(O2CC6H5)](BPh4)2 by combining 2 equiv of Fe(O3SCF3)2‚
2CH3CN, 1 equiv of H-HPTP‚4HClO4, 1 equiv of ArCOOH, and
6 equiv of Et3N in methanol, stirring for 30 min, and then precip-
itating the complexes with the addition of 2 equiv of NaBPh4.
Recrystallization from CH3CN/ether afforded analytically pure
complexes. Tetramethylammonium salts of benzoic acids were
prepared by neutralizing the acid using (Me4N)OH in MeOH/H2O
and subsequently removing the solvent under reduced pressure. The
(20) Feig, A. L.; Masschelein, Z.; Bakac, A.; Lippard, S. J. J. Am. Chem.
Soc. 1997, 119, 334-342.
1
purity of the salts was checked using H NMR.
(21) LeCloux, D. D.; Barrios, A. M.; Mizoguchi, T. J.; Lippard, S. J. J.
Am. Chem. Soc. 1998, 120, 9001-9014.
[FeII2(HPTP)(O2CC6H5)](BPh4)2. Anal. for (1)(BPh4)2 or
C82H74B2Fe2N6O3, Calcd (Found): C, 74.34 (74.35); H, 5.63 (5.73);
N, 6.34 (6.29). λmax (ꢀ, M-1 cm-1) in MeCN: 326 (2200), 400 sh.
[FeII2(HPTP)(O2CC6H4-p-Cl)](BPh4)2. Anal. for (2)(BPh4)2
orC82H73B2ClFe2N6O3, Calcd (Found): C, 72.46 (72.45); H, 5.41
(5.48); N, 6.18 (6.31). λmax (ꢀ, M-1 cm-1) in MeCN: 324 (2400),
375 sh.
(22) Kryatov, S. V.; Rybak-Akimova, E. V.; MacMurdo, V. L.; Que, L.,
Jr. Inorg. Chem. 2001, 40, 2220-2228.
(23) Chavez, F. A.; Ho, R. Y. N.; Pink, M.; Young, V. G., Jr.; Kryatov, S.
V.; Rybak-Akimova, E. V.; Andres, H. P.; Mu¨nck, E.; Que, L., Jr.;
Tolman, W. B. Angew. Chem., Int. Ed. 2002, 149-152.
(24) Dong, Y.; Me´nage, S.; Brennan, B. A.; Elgren, T. E.; Jang, H. G.;
Pearce, L. L.; Que, L., Jr. J. Am. Chem. Soc. 1993, 115, 1851-1859.
(25) LeCloux, D. D.; Barrios, A. M.; Lippard, S. J. Bioorg. Med. Chem.
1999, 7, 763-772.
(26) Tolman, W. B. Acc. Chem. Res. 1997, 30, 227-237.
(27) Que, L., Jr.; Tolman, W. B. Angew. Chem., Int. Ed. 2002, 41, 1114-
1137.
(33) Abbreviations used: BIPhMe ) 2,2′-bis(1-methylimidazolyl)phenyl-
methoxymethane; BPMP
) 2,6-bis[[bis(2-pyridylmethyl)amino]-
methyl]-4-methylphenolate; ∆9D ) stearoyl acyl carrier protein ∆9-
desaturase; HPTP ) anion of N,N,N′,N′-tetrakis(2-pyridylmethyl)-2-
hydroxy-1,3-diaminopropane; Me3TACN ) 1,4,7-trimethyl-1,4,7-tri-
azacyclononane; 6-Me4-HPTP ) anion of N,N,N′,N′-tetrakis(6-methyl-
2-pyridylmethyl)-2-hydroxy-1,3-diaminopropane; MMO ) methane
monooxygenase, N-Et-HPTB ) anion of N,N,N′,N′-tetrakis[(N-ethyl-
2-benzimidazolyl)methyl]-2-hydroxy-1,3-diaminopropane; RNR, ri-
bonucleotide reductase; TpiPr2 ) hydrotris(3,5-diisopropylpyrazolyl)-
borate anion; TPPDO ) anion of N,N,N′,N′-tetrakis(6-pivalamido-2-
pyridylmethyl)-2-hydroxy-1,3-diaminopropane.
(28) Mahadevan, V.; DuBois, J. L.; Hedman, B.; Hodgson, K. O.; Stack,
T. D. P. J. Am. Chem. Soc. 1999, 121, 5583-5584.
(29) Mahadevan, V.; Henson, M. J.; Solomon, E. I.; Stack, T. D. P. J. Am.
Chem. Soc. 2000, 122, 10249-10250.
(30) Taki, M.; Itoh, S.; Fukuzumi, S. J. Am. Chem. Soc. 2001, 123, 6203-
6204.
(31) Taki, M.; Itoh, S.; Fukuzumi, S. J. Am. Chem. Soc. 2002, 124, 998-
1002.
(32) Zhang, C. X.; Liang, H.-C.; Kim, E.-i.; Shearer, J.; Helton, M. E.;
Kim, E.; Kaderli, S.; Incarvito, C. D.; Zuberbuhler, A. D.; Rheingold,
A. L.; Karlin, K. D. J. Am. Chem. Soc. 2003, 125, 634-635.
(34) McKee, V.; Zvagulis, M.; Dagdigian, J. V.; Patch, M. G.; Reed, C.
A. J. Am. Chem. Soc. 1984, 106, 4765-4772.
7520 Inorganic Chemistry, Vol. 42, No. 23, 2003